FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Pro and Con Opinions on Broadcast Ad Major Statement

[ Price : $8.95]

Several stakeholders support an FDA plan to reduce the amount of risk information in DTC broadcast ads, while one opposes it.

Database Studies Can Support sNDAs: Study

[ Price : $8.95]

A Harvard Medical School study finds it may be possible to use nonrandomized real-world data to provide supportive evidence in est...

Zolpimist Web Page, Exhibit Panels Misbranded: FDA

[ Price : $8.95]

The CDER Office of Prescription Drug Promotion warns Amherst and Magna about false and misleading statements on a Web page and exh...

Medicrea 3D-printed Titanium Interbodt Devices Cleared

[ Price : $8.95]

FDA clears a Medicrea Group 510(k) for its IB3D range of 3D-printed Titanium interbody devices with its AdapTEK in-house additive ...

Janssen Files sBLA for Datzalex in Multiple Myeloma

[ Price : $8.95]

Janssen Biotech files a supplemental BLA for Darzalex (daratumumab) and its expanded use in combination with bortezomib, melphalan...

FDA Approves Adjustable Implanted Cataract Lens

[ Price : $8.95]

FDA approves a RxSight adjustable intraocular lens for use following cataract surgery.

Latest FDA Warning Letters

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes Hubei Danjiangkou Danao Pharmaceutical and Vita-Pure.

Abuse-Deterrent Generic Opioid Guidance

[ Price : $8.95]

FDA commissioner Scott Gottlieb says the agency has issued a new guidance and taken other steps to help sponsors test and seek app...

Comments Sought on Info Collection Under 513(g) Devices

[ Price : $8.95]

Federal Register notice: FDA seeks comments on an information collection extension for 513(g) Request for Information OMB Control ...

Cytokinetics Suspends ALS Drug Program After Phase 3 Data

[ Price : $8.95]

Cytokinetics suspends its tirasemtiv drug development program after receiving disappointing data from the VITALITY-ALS Phase 3 cli...